15939924

Source:http://linkedlifedata.com/resource/pubmed/id/15939924

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0005953, umls-concept:C0017337, umls-concept:C0026764, umls-concept:C0030705, umls-concept:C0039736, umls-concept:C0205177, umls-concept:C0225336, umls-concept:C0302600
pubmed:issue	23
pubmed:dateCreated	2005-8-10
pubmed:abstractText	To study the antiangiogenic effect of thalidomide.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8309333
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Angiogenesis Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Culture Media, Conditioned, http://linkedlifedata.com/resource/pubmed/chemical/Fibroblast Growth Factor 2, http://linkedlifedata.com/resource/pubmed/chemical/Hepatocyte Growth Factor, http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger, http://linkedlifedata.com/resource/pubmed/chemical/RNA, Neoplasm, http://linkedlifedata.com/resource/pubmed/chemical/Thalidomide, http://linkedlifedata.com/resource/pubmed/chemical/VEGFA protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factor A
pubmed:status	MEDLINE
pubmed:month	Aug
pubmed:issn	0732-183X
pubmed:author	pubmed-author:BicciatoSilvioS, pubmed-author:CorradiniPaoloP, pubmed-author:DammaccoFrancoF, pubmed-author:Di PietroGiuliaG, pubmed-author:MattioliMichelaM, pubmed-author:MontefuscoVittorioV, pubmed-author:NeriAntoninoA, pubmed-author:NicoBeatriceB, pubmed-author:RibattiDomenicoD, pubmed-author:ScavelliClaudioC, pubmed-author:VaccaAngeloA
pubmed:issnType	Print
pubmed:day	10
pubmed:volume	23
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	5334-46
pubmed:dateRevised	2007-11-15
pubmed:meshHeading	pubmed-meshheading:15939924-Adult, pubmed-meshheading:15939924-Aged, pubmed-meshheading:15939924-Aged, 80 and over, pubmed-meshheading:15939924-Angiogenesis Inhibitors, pubmed-meshheading:15939924-Bone Marrow, pubmed-meshheading:15939924-Cells, Cultured, pubmed-meshheading:15939924-Culture Media, Conditioned, pubmed-meshheading:15939924-Down-Regulation, pubmed-meshheading:15939924-Endothelium, Vascular, pubmed-meshheading:15939924-Enzyme-Linked Immunosorbent Assay, pubmed-meshheading:15939924-Female, pubmed-meshheading:15939924-Fibroblast Growth Factor 2, pubmed-meshheading:15939924-Gene Expression Profiling, pubmed-meshheading:15939924-Hepatocyte Growth Factor, pubmed-meshheading:15939924-Humans, pubmed-meshheading:15939924-Lymphoma, B-Cell, pubmed-meshheading:15939924-Lymphoma, Large B-Cell, Diffuse, pubmed-meshheading:15939924-Male, pubmed-meshheading:15939924-Middle Aged, pubmed-meshheading:15939924-Multiple Myeloma, pubmed-meshheading:15939924-Paraproteinemias, pubmed-meshheading:15939924-RNA, Messenger, pubmed-meshheading:15939924-RNA, Neoplasm, pubmed-meshheading:15939924-Sarcoma, Kaposi, pubmed-meshheading:15939924-Thalidomide, pubmed-meshheading:15939924-Umbilical Veins, pubmed-meshheading:15939924-Vascular Endothelial Growth Factor A
pubmed:year	2005
pubmed:articleTitle	Thalidomide downregulates angiogenic genes in bone marrow endothelial cells of patients with active multiple myeloma.
pubmed:affiliation	Department of Internal Medicine and Clinical Oncology, Policlinico-Piazza Giulio Cesare, University of Medical School Bari, Italy. a.vacca@dimo.uniba.it
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't